198 related articles for article (PubMed ID: 955334)
1. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension.
Rabol A; Juhl E; Schmidt A; Winkler K
Digestion; 1976; 14(3):285-9. PubMed ID: 955334
[TBL] [Abstract][Full Text] [Related]
2. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
Merkel C; Gatta A; Bolognesi M; Finucci G; Battaglia G; Angeli P; Zuin R
Dig Dis Sci; 1988 Sep; 33(9):1103-9. PubMed ID: 3409797
[TBL] [Abstract][Full Text] [Related]
4. [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Valla D; Lee SS; Moreau R; Hadengue A; Sayegh R; Lebrec D
Gastroenterol Clin Biol; 1985 Dec; 9(12):877-80. PubMed ID: 3830801
[TBL] [Abstract][Full Text] [Related]
5. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy.
Panés J; Piqué JM; Bordas JM; Llach J; Bosch J; Terés J; Rodés J
Hepatology; 1994 Jan; 19(1):55-60. PubMed ID: 8276367
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
[TBL] [Abstract][Full Text] [Related]
8. Effect of vasopressin on regional splanchnic blood flows in conscious man.
Erwald R; Wiechel KL; Strandell T
Acta Chir Scand; 1976; 142(1):36-42. PubMed ID: 1266541
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
10. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs.
Blei AT; Groszmann RJ; Gusberg R; Conn HO
Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592
[TBL] [Abstract][Full Text] [Related]
11. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
12. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
13. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
[TBL] [Abstract][Full Text] [Related]
14. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
[TBL] [Abstract][Full Text] [Related]
15. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.
Annet L; Materne R; Danse E; Jamart J; Horsmans Y; Van Beers BE
Radiology; 2003 Nov; 229(2):409-14. PubMed ID: 12970464
[TBL] [Abstract][Full Text] [Related]
16. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
17. Effect of vasopressin on liver blood flow in the hypophysectomised rat.
Jenkins SA; Mooney B; Taylor I; Shields R
Digestion; 1984; 29(3):177-82. PubMed ID: 6745509
[TBL] [Abstract][Full Text] [Related]
18. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Albillos A; Rossi I; Iborra J; Lledó JL; Calleja JL; Barrios C; García P; Escartín P
J Hepatol; 1994 Jul; 21(1):88-94. PubMed ID: 7963427
[TBL] [Abstract][Full Text] [Related]
19. Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis.
Douglas JG; Forrest JA; Prowse CV; Cash JD; Finlayson ND
Gut; 1979 Jul; 20(7):565-7. PubMed ID: 488751
[TBL] [Abstract][Full Text] [Related]
20. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.
Vosmík J; Jedlicka K; Mulder JL; Cort JH
Gastroenterology; 1977 Apr; 72(4 Pt 1):605-9. PubMed ID: 300062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
